Society Health ministry asks localities to prepare plans for 3rd, 4th booster COVID-19 vaccine shots in 2022
Media-OutReach Newswire Potential Impact of Takeda's Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
Media-OutReach Newswire Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
Media-OutReach Newswire The Lancet Neurology publishes positive results of AFFiRiS' Phase 1 trial with PD01A in Parkinson’s disease patients